Related Experiment Video

Updated: Jun 1, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Rituximab-induced interstitial lung disease: case report and literature review

Aymen Zayen¹, Henda Rais, Hela Rifi

¹Salah Azaiez Institute, Tunis, Tunisia. aymen.zayen@laposte.net

|May 27, 2011

Abstract:

Rituximab, a chimeric monoclonal antibody against CD20, very rarely causes lung toxicity. Toxicity may present as interstitial lung disease, alveolar hemorrhage and adult respiratory distress syndrome. Sixteen cases of rituximab-induced interstitial lung disease (R-ILD) have been reported. With this case and a review of all other cases reported in the literature, we will try to identify the features of R-ILD, its treatment and why the early diagnosis of this complication is important.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Articles linked to this work by shared authors, journal, and citation graph.

Interval-compressed chemotherapy in patients with Ewing's sarcoma: report on feasibility and toxicity from a North African center.

Frontiers in oncology·2026

Ewing sarcoma of the first metacarpal: a rare case report with thumb-sparing resection and fibular graft reconstruction.

Frontiers in surgery·2026

Breast Cancer in the Arabian Gulf Countries.

Cancers·2023

Gut microbiota, an emergent target to shape the efficiency of cancer therapy.

Exploration of targeted anti-tumor therapy·2023

Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer.

PloS one·2022

Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge.

Clinics and practice·2022

See all related articles